| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.54 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.067 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |